NCT02938494 - Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris | Biotech Hunter

Enrollment

210

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2016

Conditions

Acne Vulgaris

Interventions

DRUG

IDP-123 Lotion

Lotion

DRUG

Tazorac Cream

Cream

DRUG

Vehicle Lotion

Lotion

DRUG

Vehicle Cream

Cream

Trial Locations (16)

19103

Valeant Site 11, Philadelphia

20850

Valeant Site 02, Rockville

27262

Valeant Site 15, High Point

27517

Valeant Site 16, Chapel Hill

33027

Valeant Site 09, Miramar

33146

Valeant Site 08, Coral Gables

33175

Valeant Site 10, Miami

40202

Valeant Site 12, Louisville

40217

Valeant Site 13, Louisville

55432

Valeant Site 07, Fridley

80915

Valeant Site 05, Colorado Springs

90036

Valeant Site 06, Los Angeles

90404

Valeant Site 01, Santa Monica

92024

Valeant Site 03, Encinitas

94538

Valeant Site 04, Fremont

95819

Valeant Site 14, Sacramento

All Listed Sponsors

lead

Bausch Health Americas, Inc.

INDUSTRY